Candesartan is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is Candesartan Cilexetil.
| Product ID | 33342-115_27e8cb6d-e88e-44ea-8f6b-8090e6111e20 |
| NDC | 33342-115 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Candesartan |
| Generic Name | Candesartan |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-12-06 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203813 |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Substance Name | CANDESARTAN CILEXETIL |
| Active Ingredient Strength | 8 mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2016-12-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA203813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-12-06 |
| Marketing Category | ANDA |
| Application Number | ANDA203813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-12-06 |
| Marketing Category | ANDA |
| Application Number | ANDA203813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-12-06 |
| Marketing Category | ANDA |
| Application Number | ANDA203813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-12-06 |
| Ingredient | Strength |
|---|---|
| CANDESARTAN CILEXETIL | 8 mg/1 |
| SPL SET ID: | 8ceb5658-b03c-475d-9ef0-2cd0645191d3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-7034 | Candesartan | Candesartan |
| 33342-114 | Candesartan | Candesartan |
| 33342-115 | Candesartan | Candesartan |
| 33342-116 | Candesartan | Candesartan |
| 33342-117 | Candesartan | Candesartan |